What the heck is going on with the PainChek (ASX:PCK) share price?

It's been a strange few days on the ASX for PainChek…

| More on:
Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

PainChek Ltd (ASX: PCK) has been dealt a speeding ticket today following its share price and trading volume taking off over the past few days.

The company's stock finished last Thursday's session trading at 4.5 cents. Since then, it has surged more than 44% despite no word having been released by the company.

At the time of writing, the PainChek share price is 6.5 cents, the same as it was at yesterday's close.

Let's take a closer look at what's been happening with PainChek's stock lately.

A quick refresher

PainChek develops and markets its PainChek app.

The app uses artificial intelligence, facial recognition, and smart phone technology to assess pain levels of people who can't verbalise or self-report their pain.  

What's happening with the PainChek share price?

It's been a crazy couple of days for PainChek on the ASX.

More than 23 million of its shares have swapped hands since Friday's open. For context, the average day over the last 4 weeks has seen around 3.1 million PainChek securities traded.

Additionally, the PainChek share price soared 35.5% on Friday and another 6.5% yesterday.

It was in the green again earlier today amid the release of a 'please explain' issued by the ASX. In response, the company said it was as confused as anyone else about the change in trading behaviour.

Making the increased price and volume more head-scratching, is the fact the company hasn't released any price-sensitive news to the market in more than a month.

In fact, the last time the ASX heard price-sensitive news from PainChek was in October when it updated the market on its performance over the September quarter.

Though, it published its non-price-sensitive annual general meeting investor update earlier today.

At its current share price, PainChek has a market capitalisation of around $74 million.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »